About Ocuphire Pharma, Inc. 
Ocuphire Pharma, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 6 Schemes (5.78%)
Foreign Institutions
Held by 9 Foreign Institutions (0.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Sep 2025)
Net Profit:
-17 Million
Pharmaceuticals & Biotechnology
USD 163 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-4.99
-577.66%
27.28






